Clevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP)

Completed · Phase 3

Conditions studied: Hypertension

In brief

The purpose of this study is to establish the safety of clevidipine in the treatment of perioperative hypertension. Approximately 250-500 patients with perioperative hypertension undergoing coronary artery bypass grafting (CABG), off-pump coronary artery bypass (OPCAB) or minimally invasive direct coronary artery bypass (MIDCAB) surgery and/or valve replacement/repair procedures were anticipated to be randomly assigned to one of two treatment groups: clevidipine or sodium nitroprusside.

Key facts

Study ID
NCT00093912
Run by
The Medicines Company
People needed
739
Starts
2004-06-01
Expected to finish
2006-11-01
Last updated by the study team
2014-05-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.